Hansoh Pharmaceutical Group Company Limited
HKEX:3692.HK
17.7 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q2 | 2016 Q1 | 2015 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 6,505.501 | 5,592.589 | 4,511.217 | 4,948.032 | 4,434.378 | 5,533.64 | 4,401.501 | 4,710.716 | 3,979.518 | 4,083.324 | 4,599.422 | 3,948.082 | 3,774.196 | 1,930.57 | 1,546.384 | 1,546.384 | 1,546.384 | 1,358.24 | 1,358.24 | 1,358.24 |
| Cost of Revenue
| 585.983 | 501.331 | 531.177 | 471.296 | 398.894 | 453.976 | 416.413 | 439.137 | 364.274 | 355.589 | 381.94 | 352.908 | 250.192 | 150.775 | 113.793 | 113.793 | 113.793 | 99.32 | 99.32 | 99.32 |
| Gross Profit
| 5,919.518 | 5,091.258 | 3,980.04 | 4,476.736 | 4,035.484 | 5,079.664 | 3,985.088 | 4,271.579 | 3,615.244 | 3,727.735 | 4,217.482 | 3,595.174 | 3,524.004 | 1,779.795 | 1,432.592 | 1,432.592 | 1,432.592 | 1,258.92 | 1,258.92 | 1,258.92 |
| Gross Profit Ratio
| 0.91 | 0.91 | 0.882 | 0.905 | 0.91 | 0.918 | 0.905 | 0.907 | 0.908 | 0.913 | 0.917 | 0.911 | 0.934 | 0.922 | 0.926 | 0.926 | 0.926 | 0.927 | 0.927 | 0.927 |
| Reseach & Development Expenses
| 1,196.454 | 1,167.568 | 929.478 | 954.279 | 739.035 | 1,110.083 | 686.929 | 775.869 | 476.377 | 562.832 | 557.849 | 518.679 | 362.609 | 220.322 | 143.886 | 143.886 | 143.886 | 100.766 | 100.766 | 100.766 |
| General & Administrative Expenses
| 353.898 | 379.883 | 329.961 | 305.074 | 292.386 | 510.73 | 432.693 | 410.071 | 348.57 | 388.907 | 388.785 | 421.866 | 368.292 | 89.069 | 65.12 | 65.12 | 65.12 | 58.903 | 58.903 | 58.903 |
| Selling & Marketing Expenses
| 1,720.67 | 1,861.518 | 1,669.645 | 1,867.374 | 1,682.856 | 1,898.676 | 1,529.142 | 1,655.591 | 1,447.427 | 1,456.156 | 1,810.224 | 1,650.123 | 1,558.557 | 802.17 | 676.05 | 676.05 | 676.05 | 594.51 | 594.51 | 594.51 |
| SG&A
| 2,074.568 | 2,241.401 | 1,999.606 | 2,172.448 | 1,975.242 | 2,409.406 | 1,961.835 | 2,065.662 | 1,795.997 | 1,845.063 | 2,199.009 | 2,071.989 | 1,926.849 | 891.239 | 741.17 | 741.17 | 741.17 | 653.413 | 653.413 | 653.413 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.38 | 100.098 | 100.098 | 74.822 | 74.822 | 74.822 | 59.409 | 59.409 | 59.409 |
| Operating Expenses
| 3,271.022 | 3,408.969 | 2,863.727 | 3,184.04 | 2,653.126 | 3,416.442 | 2,549.261 | 2,742.394 | 2,208.401 | 2,403.961 | 2,719.661 | 2,575.438 | 2,254.942 | 1,211.659 | 959.878 | 959.878 | 959.878 | 813.588 | 813.588 | 813.588 |
| Operating Income
| 2,648.496 | 1,682.289 | 1,044.209 | 1,377.937 | 1,229.546 | 1,484.267 | 1,336.324 | 1,430.048 | 1,342.87 | 1,319.84 | 1,460.624 | 1,004.506 | 1,234.546 | 577.331 | 483.198 | 483.198 | 483.198 | 451.922 | 451.922 | 451.922 |
| Operating Income Ratio
| 0.407 | 0.301 | 0.231 | 0.278 | 0.277 | 0.268 | 0.304 | 0.304 | 0.337 | 0.323 | 0.318 | 0.254 | 0.327 | 0.299 | 0.312 | 0.312 | 0.312 | 0.333 | 0.333 | 0.333 |
| Total Other Income Expenses Net
| 469.69 | 583.983 | 455.674 | 61.367 | 279.578 | 268.759 | 210.732 | 174.657 | 150.724 | 135.727 | 84.734 | 26.788 | 43.485 | 0 | 0 | 0 | 0 | -0.853 | -0.853 | -0.853 |
| Income Before Tax
| 3,118.186 | 2,266.272 | 1,499.883 | 1,439.304 | 1,509.124 | 1,753.026 | 1,547.056 | 1,604.705 | 1,493.594 | 1,455.567 | 1,545.358 | 1,031.294 | 1,278.031 | 577.331 | 483.198 | 483.198 | 483.198 | 451.07 | 451.07 | 451.07 |
| Income Before Tax Ratio
| 0.479 | 0.405 | 0.332 | 0.291 | 0.34 | 0.317 | 0.351 | 0.341 | 0.375 | 0.356 | 0.336 | 0.261 | 0.339 | 0.299 | 0.312 | 0.312 | 0.312 | 0.332 | 0.332 | 0.332 |
| Income Tax Expense
| 392.661 | 277.617 | 211.035 | 153.533 | 211.148 | 330.714 | 256.466 | 257.632 | 271.76 | 194.862 | 249.321 | 170.553 | 235.724 | 101.569 | 84.33 | 84.33 | 84.33 | 82.061 | 82.061 | 82.061 |
| Net Income
| 2,725.525 | 1,988.655 | 1,288.848 | 1,285.771 | 1,297.976 | 1,422.312 | 1,290.59 | 1,347.073 | 1,221.834 | 1,260.705 | 1,296.037 | 860.741 | 1,042.307 | 475.762 | 398.868 | 398.868 | 398.868 | 369.009 | 369.009 | 369.009 |
| Net Income Ratio
| 0.419 | 0.356 | 0.286 | 0.26 | 0.293 | 0.257 | 0.293 | 0.286 | 0.307 | 0.309 | 0.282 | 0.218 | 0.276 | 0.246 | 0.258 | 0.258 | 0.258 | 0.272 | 0.272 | 0.272 |
| EPS
| 0.46 | 0.3 | 0.22 | 0.22 | 0.22 | 0.24 | 0.2 | 0.23 | 0.21 | 0.22 | 0.25 | 0.17 | 0.21 | 0.083 | 0.07 | 0.07 | 0.07 | 0.065 | 0.065 | 0.065 |
| EPS Diluted
| 0.46 | 0.33 | 0.22 | 0.22 | 0.22 | 0.24 | 0.22 | 0.23 | 0.21 | 0.22 | 0.25 | 0.17 | 0.21 | 0.083 | 0.07 | 0.07 | 0.07 | 0.065 | 0.065 | 0.065 |
| EBITDA
| 2,801.819 | 1,806.196 | 1,218.782 | 1,554.163 | 1,377.692 | 1,623.272 | 1,460.74 | 1,543.766 | 1,445.502 | 1,412.804 | 1,551.335 | 1,083.443 | 1,304.233 | 617.105 | 517.701 | 517.701 | 517.701 | 482.248 | 482.248 | 482.248 |
| EBITDA Ratio
| 0.431 | 0.323 | 0.27 | 0.314 | 0.311 | 0.293 | 0.332 | 0.328 | 0.363 | 0.346 | 0.337 | 0.274 | 0.346 | 0.32 | 0.335 | 0.335 | 0.335 | 0.355 | 0.355 | 0.355 |